Seegene Inc

Select Menu

Press Release You can check out news about Seegene from various media

Nov. 30
2021

Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

- The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube. - Seegene will support countries in need of diagnostics to hel...

PR Newswire
Nov. 23
2021

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

- Q3 Revenue held steady at KRW 305.3 billion- Operating profit dipped slight due to powerful investment in R&D- Scheduled to introduce new diagnostic tests capable of screening 22 targets, i...

PR Newswire
Nov. 15
2021

Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing

Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx), has announced the opening of an eighth global subsidiary, strategically located in Bogotá, Colombi...

PR Newswire
Oct. 27
2021

Launch of Seegene’s STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

- A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories- Utilizes Seegene’s ...

PR Newswire
Sep. 27
2021

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

- Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in the Atlanta, GA, United States- AIOS is the MDx system that integrates Seegene’s ...

PR Newswire
Sep. 01
2021

Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests

Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company announced on August 20, that it has obtained CE marking for the use of Combo Swab, a self-collection device with four d...

PR Newswire
Aug. 16
2021

Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY

- Revenue of KRW 303.7 billion ($269.1 million) is record for second quarter, up 11 percent year-over-year - 1H’21 Revenue at KRW 655.5 billion ($580.8 million), 58 percent achievement based on t...

PR Newswire
Jul. 13
2021

Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus

- Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. - The ...

PR Newswire
Jun. 30
2021

Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market

- Seegene announces partnership with Bio-Rad for the development and commercialization of infectious disease molecular diagnostic products - Diagnostic tests designed for the pandemic and the po...

PR Newswire
Jun. 29
2021

Seegene unveils "MOBILE STATION," for on-site routine testing at public-use facilities and communities

- Seegene unveils "MOBILE STATION" at the Medlab Middle East 2021 - Mobile laboratory designed for mass testing at schools, airports, or communities, delivering test results within 3h 30min with ...

PR Newswire
May. 24
2021

Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID

Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year’s European Con...

PR Newswire
May. 12
2021

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

- SEEGENE POSTS KRW 193.9 BIL. IN OPERATING PROFIT, UP 388% ON-YEAR - OPERATING PROFIT RATIO AT 55%, DESPITE CONSTANT INVESTMENT IN R&D AND EMPLOYEES Seegene Inc. (KQ 096530), a molecular di...

PR Newswire
May. 11
2021

Seegene’s Germany subsidiary supports the back-to-school initiative with its COVID-19 tests

- SEEGENE BACKS GERMANY IN ITS EFFORT TO RETURN TO NORMALCY - GERMAN SUBSIDIARY TO SUPPLY COVID-19 DIAGNOSTIC TESTS ENOUGH TO TEST 734,000 PUPILS Seegene Inc. (KQ 096530), a leading molecul...

PR Newswire
Apr. 22
2021

Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year

Second public procurement agreement after Italy’s procurement deal worth EUR 89.3 million Seegene Inc. (KQ 096530), a leading biotechnology firm said it began supplying its COVID-19 diagnostic te...

PR Newswire

1 2 3 4 5

Choose your location

Choose your country

Press Release You can check out news about Seegene from various media

Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing

Launch of Seegene’s STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests

Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY

Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus

Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market

Seegene unveils "MOBILE STATION," for on-site routine testing at public-use facilities and communities

Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

Seegene’s Germany subsidiary supports the back-to-school initiative with its COVID-19 tests

Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year